| Literature DB >> 25759715 |
Hanna Karen M Antunes1, Marco Túlio De Mello2, Valdir de Aquino Lemos2, Ruth Ferreira Santos-Galduróz3, Luciano Camargo Galdieri4, Orlando Francisco Amodeo Bueno5, Sergio Tufik5, Vânia D'Almeida5.
Abstract
BACKGROUND: Physical exercise influences homocysteine (Hcy) concentrations, cognitive function and the metabolic profile. The purpose of this study was to investigate the influence of regular physical exercise on Hcy levels, the metabolic profile and cognitive function in healthy elderly males before and after an endurance exercise program.Entities:
Keywords: Aerobic training; Cognitive function; Elderly subjects; Homocysteine; Metabolic profile; Physical exercise
Year: 2015 PMID: 25759715 PMCID: PMC4335628 DOI: 10.1159/000369160
Source DB: PubMed Journal: Dement Geriatr Cogn Dis Extra ISSN: 1664-5464
Characteristics of the sample
| Variables | Control group | Experimental group |
|---|---|---|
| Age, years | 66.00 ± 3.84 | 68.09 ± 5.49 |
| Weight, kg | 77.02 ± 10.94 | 77.56 ± 13.46 |
| Height, m | 1.68 ± 0.06 | 1.69 ± 0.09 |
| BMI | 27.83 ± 3.07 | 27.06 ± 3.76 |
Fig. 1Summary of the experimental design. The volunteers (n = 45) were randomized into 2 groups: a control group (n = 23) and an experimental group (n = 22).
Effect of physical exercise on cognitive function
| Variables | Control group | Experimental group | ||
|---|---|---|---|---|
| baseline | after intervention | baseline | after intervention | |
| Digit symbol | 36.41 ± 18.59 | 29.64 ± 8.00 | 32.48 ± 11.21 | 38.87 ± 8.03 |
| Similarities test | 17.68 ± 3.81 | 18.55 ± 2.77 | 17.09 ± 3.82 | 18.48 ± 2.94 |
| Mental control | 5.05 ± 1.17 | 5.36 ± 0.90 | 5.04 ± 1.30 | 5.52 ± 0.85 |
| Picture arrangement | 8.77 ± 2.79 | 9.50 ± 3.20 | 9.65 ± 4.79 | 11.70 ± 2.75 |
| Block design | 18.32 ± 7.43 | 18.82 ± 5.59 | 17.91 ± 12.66 | 23.83 ± 9.61 |
| ROCF test | ||||
| Copy | 32.20 ± 3.76 | 33.0 ± 2.9 | 32.09 ± 4.12 | 33.24 ± 2.33 |
| Immediate recall | 11.68 ± 6.97 | 13.0 ± 7.4 | 14.50 ± 7.61 | 16.33 ± 7.01 |
| Delayed recall | 11.91 ± 6.94 | 12.4 ± 7.7 | 13.35 ± 7.70 | 15.24 ± 7.37 |
| Digit span | ||||
| Forward | 5.73 ± 2.31 | 5.64 ± 2.04 | 5.57 ± 1.93 | 7.26 ± 1.66 |
| Backward | 5.14 ± 2.49 | 5.59 ± 2.20 | 5.48 ± 2.43 | 6.00 ± 1.91 |
| Toulouse-Piéron test | ||||
| Number of cancellations | 91.95 ± 33.10 | 83.68 ± 27.23 | 77.70 ± 25.70 | 99.43 ± 31.91 |
| Number of errors | 9.59 ± 7.59 | 9.50 ± 8.12 | 9.04 ± 11.45 | 5.43 ± 5.53 |
| WCST | ||||
| Number of trials | 67.09 ± 17.10 | 69.59 ± 16.19 | 64.39 ± 24.44 | 88.74 ± 13.69 |
| Number of errors | 61.05 ± 18.38 | 58.41 ± 16.19 | 59.83 ± 22.72 | 39.26 ± 13.69 |
| Categories | 3.59 ± 2.13 | 3.77 ± 1.97 | 4.09 ± 2.48 | 6.35 ± 2.27 |
Data are presented as means ± SD. ANOVA for repeated measurement followed by the Duncan post hoc test.
p ≤ 0.05 vs. baseline intragroup condition
p ≤ 0.05 vs. postintervention intergroup condition.
Fig. 2Results of the analysis of plasma Hcy concentrations. Bars denote means, whiskers are SD. No statistical differences were observed when the groups were compared.
Ergospirometric evaluation
| Control group | Experimental group | |||
|---|---|---|---|---|
| Variables | baseline | after intervention | baseline | after intervention |
| Peak VO2, l·min–1 | 1.20 ± 0.30 | 1.10 ± 0.30 | 1.40 ± 0.30 | 1.40 ± 0.30 |
| Peak VO2, ml·kg·min–1 | 15.40 ± 3.90 | 14.90 ± 3.70 | 18.60 ± 4.80 | 19.20 ± 4.20 |
| Maximum heart rate, bpm | 130.10 ± 16.80 | 131.00 ± 24.50 | 127.50 ± 22.70 | 124.70 ± 16.60 |
| VO2 at VT-1 intensity, l·min–1 | 0.80 ± 0.30 | 0.80 ± 0.30 | 0.90 ± 0.30 | 1.00 ± 0.20 |
| VO2 at VT-1 intensity, ml·kg·min–1 | 11.30 ± 3.10 | 13.90 ± 14.40 | 12.40 ± 3.30 | 14.40 ± 3.10 |
| Heart rate at VT-1 intensity, bpm | 107.60 ± 13.20 | 107.80 ± 18.80 | 102.60 ± 16.80 | 109.80 ± 15.50 |
| Maximum ventilation, l·min–1 | 49.20 ± 17.10 | 46.70 ± 15.70 | 54.90 ± 14.20 | 56.10 ± 11.10 |
| Workload at VT-1 intensity, W | 50.00 ± 16.80 | 53.20 ± 15.60 | 50.30 ± 26.80 | 98.90 ± 31.50 |
Data are presented as means ± SE. ANOVA for repeated measurement followed by the Duncan post hoc test.
p ≤ 0.05 vs. baseline intragroup condition
p ≤ 0.05 vs. postintervention intergroup condition.
Effect of physical exercise on metabolic parameters
| Control group | Experimental group | |||
|---|---|---|---|---|
| Variables | baseline | after intervention | baseline | after intervention |
| Uric acid, mg/dl | 6.39 ± 0.21 | 6.56 ± 0.34 | 5.93 ± 0.28 | 6.09 ± 0.27 |
| Hemoglobin, g/dl | 15.65 ± 0.20 | 15.20 ± 0.26 | 15.63 ± 0.18 | 15.18 ± 0.24 |
| Hematocrit, % | 46.16 ± 0.57 | 46.99 ± 0.69 | 45.31 ± 0.65 | 44.11 ± 0.63 |
| Platelets, 103/mm3 | 217.32 ± 15.70 | 211.52 ± 17.32 | 229.78 ± 12.42 | 218.91 ± 12.39 |
| Bilirubin, mg/dl | 0.90 ± 0.16 | 0.86 ± 0.12 | 1.17 ± 0.09 | 0.90 ± 0.08 |
| Cholesterol, mg/dl | 207.45 ± 5.70 | 199.00 ± 6.59 | 195.64 ± 7.89 | 173.23 ± 6.98 |
| HDL, mg/dl | 53.59 ± 3.63 | 49.33 ± 3.36 | 52.59 ± 3.42 | 58.50 ± 2.11 |
| LDL, mg/dl | 127.18 ± 6.20 | 123.83 ± 6.89 | 118.16 ± 7.01 | 114.10 ± 5.96 |
| VLDL, mg/dl | 25.99 ± 2.13 | 24.62 ± 2.52 | 27.79 ± 3.44 | 28.56 ± 2.87 |
| Creatinine, mg/dl | 1.16 ± 0.04 | 1.10 ± 0 | 1.04 ± 0.05 | 0.75 ± 0.15 |
| Alkaline phosphatase, U/l | 102.69 ± 10.43 | 72.37 ± 8.38 | 100.43 ± 16.91 | 71.17 ± 12.12 |
| GGT, U/l | 45.35 ± 7.71 | 45.26 ± 7.38 | 43.73 ± 19.03 | 55.30 ± 17.19 |
| SGOT, U/l | 24.57 ± 1.86 | 22.78 ± 1.24 | 30.38 ± 3.53 | 29.13 ± 3.07 |
| SGPT, U/l | 27.79 ± 2.01 | 26.22 ± 2.27 | 31.77 ± 4.57 | 30.30 ± 2.76 |
| Triglycerides, mg/dl | 143.09 ± 17.44 | 138.52 ± 19.53 | 150.83 ± 20.08 | 107.78 ± 14.35 |
| Urea, mg/dl | 35.58 ± 2.30 | 33.48 ± 1.69 | 29.15 ± 1.49 | 33.28 ± 1.49 |
| Glucose, mg/dl | 98.82 ± 2.55 | 93.81 ± 3.10 | 103.61 ± 3.26 | 93.30 ± 2.66 |
| T3, ng/dl | 106.05 ± 6.14 | 97.51 ± 6.58 | 106.27 ± 3.74 | 91.48 ± 2.62 |
| T4, ng/dl | 8.00 ± 0.39 | 7.38 ± 0.43 | 8.08 ± 0.29 | 6.59 ± 0.22 |
| TSH, μIU/ml | 3.73 ± 0.95 | 3.66 ± 0.87 | 2.53 ± 0.42 | 2.29 ± 0.25 |
| PSA, ng/dl | 1.97 ± 0.31 | 1.90 ± 0.32 | 2.20 ± 0.47 | 1.30 ± 0.23 |
Data are presented as means ± SD. ANOVA for repeated measurement followed by the Duncan post hoc test.
p ≤ 0.05 vs. baseline intragroup condition
p ≤ 0.05 vs. postintervention intergroup condition. GGT = γ-Glutamyl transferase; SGPT = serum glutamic pyruvic transaminase; SGOT = serum glutamic oxaloacetic transaminase; TSH = thyroid-stimulating hormone.